» Articles » PMID: 38213402

Magnesium Supplementation Beneficially Affects Depression in Adults with Depressive Disorder: a Systematic Review and Meta-analysis of Randomized Clinical Trials

Overview
Specialty Psychiatry
Date 2024 Jan 12
PMID 38213402
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The findings from randomized clinical trials (RCTs) examining the effect of magnesium supplementation on depression are inconsistent. We decided to conduct a meta-analysis that summarizes all the evidence on the impact of magnesium supplementation on depression scores in adults with depressive disorder.

Methods: We conducted a systematic search in the online databases using all related keywords up to July 2023. We included all randomized clinical trials examining the effect of magnesium, in contrast to placebo, on depression scores.

Results: Finally, seven clinical trials were included in this systematic review, building up a total sample size of 325 individuals with ages ranging from 20 to 60 years on average. These RCTs resulted in eight effect sizes. Our findings from the meta-analysis showed a significant decline in depression scores due to intervention with magnesium supplements [standardized mean difference (SMD): -0.919, 95% CI: -1.443 to -0.396,  = 0.001].

Conclusion: Our review suggests that magnesium supplementation can have a beneficial effect on depression. Future high-quality RCTs with larger sample sizes must be run to interpret this effect of magnesium on depression in clinical settings.

Systematic Review Registration: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=447909.

Citing Articles

Beyond Diabetes: Semaglutide's Role in Modulating Mood Disorders through Neuroinflammation Pathways.

Piatkowska-Chmiel I, Wicha-Komsta K, Pawlowski K, Syrytczyk A, Kocki T, Dudka J Cell Mol Neurobiol. 2025; 45(1):22.

PMID: 40059125 PMC: 11891103. DOI: 10.1007/s10571-025-01534-4.


The Novel Imipramine-Magnesium Complex Exerts Antidepressant-like Activity in Mice Subjected to the Forced Swim Test and the Tail Suspension Test.

Serefko A, Lachowicz-Radulska J, Szopa A, Herbet M, Czylkowska A, Ignatiuk K Molecules. 2025; 30(3).

PMID: 39942624 PMC: 11820773. DOI: 10.3390/molecules30030519.


Magnesium depletion score and depression: a positive correlation among US adults.

Zhao W, Jin H Front Public Health. 2024; 12:1486434.

PMID: 39564360 PMC: 11573693. DOI: 10.3389/fpubh.2024.1486434.


Magnesium Matters: A Comprehensive Review of Its Vital Role in Health and Diseases.

Fatima G, Dzupina A, B Alhmadi H, Magomedova A, Siddiqui Z, Mehdi A Cureus. 2024; 16(10):e71392.

PMID: 39539878 PMC: 11557730. DOI: 10.7759/cureus.71392.


Diagnosis and Treatment of Eclampsia.

Katsi V, Svigkou A, Dima I, Tsioufis K J Cardiovasc Dev Dis. 2024; 11(9).

PMID: 39330315 PMC: 11432638. DOI: 10.3390/jcdd11090257.


References
1.
Afsharfar M, Shahraki M, Shakiba M, Asbaghi O, Dashipour A . The effects of magnesium supplementation on serum level of brain derived neurotrophic factor (BDNF) and depression status in patients with depression. Clin Nutr ESPEN. 2021; 42:381-386. DOI: 10.1016/j.clnesp.2020.12.022. View

2.
Abiri B, Sarbakhsh P, Vafa M . Randomized study of the effects of vitamin D and/or magnesium supplementation on mood, serum levels of BDNF, inflammation, and SIRT1 in obese women with mild to moderate depressive symptoms. Nutr Neurosci. 2021; 25(10):2123-2135. DOI: 10.1080/1028415X.2021.1945859. View

3.
Tarleton E, Littenberg B, MacLean C, Kennedy A, Daley C . Role of magnesium supplementation in the treatment of depression: A randomized clinical trial. PLoS One. 2017; 12(6):e0180067. PMC: 5487054. DOI: 10.1371/journal.pone.0180067. View

4.
Serefko A, Szopa A, Poleszak E . Magnesium and depression. Magnes Res. 2016; 29(3):112-119. DOI: 10.1684/mrh.2016.0407. View

5.
Evans D, Charney D . Mood disorders and medical illness: a major public health problem. Biol Psychiatry. 2003; 54(3):177-80. DOI: 10.1016/s0006-3223(03)00639-5. View